The episode investigates baclofen, a muscle relaxant, as a potential treatment for alcohol and drug addiction, based on anecdotal reports and early research. It highlights a paraplegic patient's accidental discovery that high-dose baclofen eliminated cocaine cravings, inspiring off-label use and patient-led experimentation. The discussion extends to other anti-craving medications and the neuroscience of addiction as a hijacked reward system.
Why listen
It reveals how a forgotten muscle drug may short-circuit addiction by targeting the brain's craving circuitry—a radical shift from moral to medical models of recovery.
Key takeaways
01High-dose baclofen may eliminate alcohol and drug cravings in some individuals, though evidence remains anecdotal and off-label.
02Addiction may stem from an overactive reward sensitivity system—evolutionarily advantageous but maladaptive in modern environments with abundant stimuli.
03Patients are crowdsourcing dosing strategies for addiction medications online due to lack of clinical guidance, especially for baclofen.
Best for
people affected by addictionhealthcare providers exploring off-label treatmentslisteners interested in neuroscience of craving